Sumitomo Mitsui Ds Asset Management Company, LTD Alnylam Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $9.6 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 11,611 shares of ALNY stock, worth $2.89 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,611
Previous 11,581
0.26%
Holding current value
$2.89 Million
Previous $3.19 Million
14.22%
% of portfolio
0.03%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.13 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.17 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.38 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.73 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.09 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...